Aradhana Sarin, Director Board of Governors, Audit Chair at American Red Cross, Board Director, Member Audit at AB InBev, shared a post on LinkedIn:
“Like every year, a busy and inspiring few days at ASCO26.
It was another incredibly valuable opportunity to spend time with a wide variety of leaders across the oncology community, hear different perspectives, and learn more about groundbreaking advances across cancer care.
Our Finance teams that support both Oncology Commercial and Oncology R&D were present in full force after all, they need to help make very important capital allocation decisions. At our Investor and Analyst event, we shared our portfolio and our progress in multiple new medicines.
I was also delighted to take part in the launch of the Oncology chapter of the AZ Network of Women (NoW) at ASCO, to moderate a discussion on how allies (Mohit Manrao,Sunil Verma) can support the growth and advancement of women in this field.
And of course, no ASCO would be complete without a hug from the canine companions that offer comfort and hope to so many cancer patients in their journeys.
I want to congratulate all the sponsors, leaders and employees from AstraZeneca Oncology who helped make our participation, and the NoW launch, a huge success!”
Other articles featuring Aradhana Sarin on OncoDaily.
